Christoph Hölscher
8PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 18, 2025
The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis.Andreas Römpp, Axel Treu, Julia Kokesch-Himmelreich
|Sep 23, 2022
High-Dose Mycobacterium tuberculosis H37rv Infection in IL-17A- and IL-17A/F-Deficient Mice.Kristina Ritter, Jochen Behrends, Dominik Rückerl
|Dec 06, 2021
Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas.Kerstin Walter, Julia Kokesch-Himmelreich, Axel Treu
|Oct 31, 2021
Gasdermin D mediates host cell death but not interleukin-1β secretion in Mycobacterium tuberculosis-infected macrophages.Sebastian J Theobald, Jessica Gräb, Melanie Fritsch
|Sep 27, 2021
Correction to: Interleukin‑23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin‑17A.Kristina Ritter, Jochen Behrends, Hanna Erdmann
|Aug 05, 2021
Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A.Kristina Ritter, Jochen Behrends, Hanna Erdmann
Pageof 2
Frequent Collaborators
2 joint publications
Jochen Behrends
1 joint publications
Hantao Zhao
1 joint publications
Tyler Thrash
1 joint publications
Mubbasir Kapadia
1 joint publications
Mehdi Moussaïd
1 joint publications
Victor R Schinazi
1 joint publications
Manolis Pasparakis
1 joint publications
Jan Rybniker
1 joint publications
Dominik Rückerl
1 joint publications
Immo Prinz
